Furthermore, when methylated C9orf50 and methylated KCNQ5 were combined, the clinical performance for CRC detection was similar to that of methylated C9orf50 alone, 88.4 vs. 85.9% for sensitivity and 89.4 vs. 95.0% for specificity. The gene discussed is C9orf50; the disease is colorectal carcinoma.